Phase II Study of Gonadotropin-Releasing Hormone Analog for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

PURPOSE. Premature ovarian failure occurs in 40%–70% of patients who receive conventional chemotherapy alone. However, the incidence is higher, 70%–100%, in patients who undergo myeloablative chemotherapy with hematopoietic stem cell transplantation (HSCT). Gonadotropin-releasing hormone (GnRH) anal...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng, Yee Chung, Takagi, Mariko, Milbourne, Andrea, Champlin, Richard E., Ueno, Naoto T.
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2012
Subjects:
Gynecologic Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286172/
https://ncbi.nlm.nih.gov/pubmed/22282904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0205
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items